Lori Lawley
2023
In 2023, Lori Lawley earned a total compensation of $569.8K as Chief Financial Officer at NewLink Genetics, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $109,480 |
|---|---|
| Option Awards | $28,026 |
| Salary | $391,000 |
| Stock Awards | $3,520 |
| Other | $37,749 |
| Total | $569,775 |
Lawley received $391K in salary, accounting for 69% of the total pay in 2023.
Lawley also received $109.5K in non-equity incentive plan, $28K in option awards, $3.5K in stock awards and $37.7K in other compensation.
Rankings
In 2023, Lori Lawley's compensation ranked 1,884th out of 3,006 executives tracked by ExecPay. In other words, Lawley earned more than 37.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,884 out of 3,006 | 37th |
Division Manufacturing | 1,085 out of 1,650 | 34th |
Major group Chemicals And Allied Products | 678 out of 918 | 26th |
Industry group Drugs | 661 out of 881 | 25th |
Industry Pharmaceutical Preparations | 472 out of 637 | 26th |
Source: SEC filing on April 12, 2024.
Lawley's colleagues
We found two more compensation records of executives who worked with Lori Lawley at NewLink Genetics in 2023.
News
NewLink Genetics CEO Richard Hawkins' 2023 pay falls 25% to $953K
April 12, 2024
NewLink Genetics CEO Richard Hawkins' 2022 pay slips 6% to $1.3M
March 31, 2023
NewLink Genetics CSO John McKew's 2021 pay rises 15% to $1.4M
March 23, 2022
NewLink Genetics CEO Richard Hawkins' 2020 pay jumps 200% to $2.2M
April 6, 2021